How the Moderna vaccine stacks up against Pfizer/BioNTech’s
By Michael Erman NEW YORK (Reuters) – U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for
By Michael Erman NEW YORK (Reuters) – U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for
Here are five things you must know for Thursday, Dec. 17: 1. — Stock Futures
Exiger President of Global Markets Brandon Daniels discusses the logistical challenges that can come with
Take a look at some of the biggest movers in the premarket: Moderna (MRNA) –
After a modest ricochet off 1.20 yesterday, the is again on the back foot alongside
What happened Shares of the COVID-19 vaccine developers Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) are both
U.S. biotech company Moderna Inc. MRNA focused on drug discovery and development based exclusively on
By Julie Steenhuysen CHICAGO (Reuters) – Moderna Inc’s experimental vaccine for COVID-19 showed it was